Rigel Pharmaceuticals Inc

Small-Cap Stocks Biotech Stocks Healthcare Stocks

$36.81

-1.25 (-3.28%)

As of Aug 8, 1:50 AM ET ·

Analyst Consensus

Buy

Analysts

Moderate

Coverage

Buy 8 73%

Hold 3 27%

Sell 0 0%

Price Target

Analyst Price Target +47.0% upside

Low Target $39.68

Average Target $54.10

High Target $74.39

Current Price $36.81

Current
$36.81

Target
$54.10

$39.68 $54.10 avg $74.39

Scenario Analysis

Bear Case

$39.68

7.8%

Low target

Base Case

$54.10

+47.0%

Avg target

Bull Case

$74.39

+102.1%

High target

Risk/Reward

13.1x

Highly favorable

Price in Context

52-Week High

$52.24

-29.5% from high

52-Week Low

$24.95

+47.5% from low

Target vs 52W High

$54.10

+3.6% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	39	79%	$257.58	+4.7%
AMGN Amgen Inc	Hold	43	49%	$190.87	-53.6%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+172.3%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	40	83%	$438.34	-11.6%
REGN Regeneron Pharmaceuticals	Buy	38	71%	$76.80	-90.2%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-55.6%
RVMD Revolution Medicines Inc	Strong Buy	29	93%	$114.11	-44.4%
BIIB Biogen Inc	Buy	44	64%	$91.45	-56.0%